GSK to fund startups through venture capital partnership

04/23/2013 | Wall Street Journal, The · Reuters

GlaxoSmithKline and Avalon Ventures, a venture capital firm, will fund up to 10 early-stage drug developers over the next three years. GSK will provide technical support and up to $465 million in initial funding and milestone payments, and will have first rights to buy each startup.

View Full Article in:

Wall Street Journal, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Actuary
NTA Life
Addison, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA